Rogue is a US-only oral nicotine brand owned by Swisher International, selling seventeen pouch flavours at 3 mg and 6 mg, four at 9/12/15 mg, and two nicotine gums — none of it authorised by the FDA. Its pouches use nicotine polacrilex rather than a cellulose-and-salt matrix, which makes them measurably heavier and slower-releasing than most of the category.
Rogue is one of the few pouch brands in the United States that is neither a cigarette company’s diversification nor a Scandinavian import. It is also one of the more technically distinctive, for a reason the marketing never mentions: it builds its pouches around the same ion-exchange resin used in pharmacy nicotine gum. That shows up in the lab data, and it is the most interesting thing about the brand.
The company
The brand belongs to Rogue Holdings, LLC, and the parent is Swisher International, Inc. — the Jacksonville cigar company, not, as is sometimes written, Turning Point Brands. Rogue’s own terms of use name the parent as the contracting party: the agreement is “between you … and Swisher International, Inc.”, and the notice address for disputes is “Rogue Holdings, LLC c/o Swisher International, Inc., Attn: VP Consumer Marketing, 459 E. 16th St., Jacksonville, FL 32206.” Swisher’s own corporate site lists Rogue Holdings as one of its eight business units and describes it as having “a portfolio spanning pouches, tablets, gum, and lozenges”.
Independent confirmation of the manufacturer name comes from three peer-reviewed papers that bought the products and named the maker — CDC’s lab lists “Rogue Holdings” among the six manufacturers it procured from, and both Altria’s and Roswell Park’s product tables carry Rogue Holdings LLC.
Two things are not on the public record. When Swisher acquired Rogue, and on what terms, is not published anywhere I could reach — Swisher is privately held, its newsroom loads client-side with no retrievable endpoint, and searches of both companies’ sites for “acquisition” return nothing. And the manufacturing location is given only as a country: every Rogue product page says the products are “made in the USA with domestic and imported ingredients”, with no plant, city or contract manufacturer named.
On the nicotine itself, the company is more forthcoming about its gum than its pouches. The gum page states that Rogue creates it “by extracting the nicotine from tobacco leaves, separating it, and combining it with food-grade ingredients”. The pouch pages make no equivalent statement — but an independent lab reached the same conclusion from the molecule: Roswell Park measured Rogue’s pouches at 100% S-nicotine and noted that “pouches containing more than 90% S-nicotine were suspected to contain nicotine derived from tobacco”. Suspected, by an isomer criterion, not proven.
The range and the strengths
Three categories exist on the manufacturer’s shop and only three: pouches, gum, and multipacks. There is no lozenge and no tablet product page, in the catalogue or in the sitemap, despite the corporate description.
| Line | Flavours | Strengths as printed | Format |
|---|---|---|---|
| Rogue Pouches | Wintergreen, Peppermint, Spearmint, Mango, Citrus, Apple, Berry, Blue Raspberry, Honey Lemon, Cinnamon, Smooth, Original, Bold | 3MG, 6MG | 20 pouches per can, 5 cans per pack |
| Rogue MAX | Wintergreen, Blue Raspberry, Spearmint, Citrus | 9 MG, 12 MG, 15 MG | packs of 5 |
| Rogue Nicotine Gum | Wintergreen, Peppermint | 4mg | 20 pieces per tin, 5 tins per pack |
So six strengths in total across the brand: 3, 6, 9, 12 and 15 mg in pouches, 4 mg in gum. The published pouch specification is thin — “Each can contains 20 pouches, and there are 5 cans per pack … Net Weight: .48oz (13.5g) per can” — and that is a can weight, not a pouch weight. No pouch mass, no pH, no moisture and no mg/g figure is published for any Rogue product.
Three inconsistencies on the manufacturer’s own site are worth knowing if you are checking a figure against it. The MAX product pages currently carry the standard boilerplate, so a page whose own selector offers 9, 12 and 15 mg also states that the pouches “come in two different nicotine strengths: 3mg and 6mg” — which means no can weight is currently published for MAX at all. The about page says there are nine flavours while the shop lists seventeen. And both gum products are labelled “Caffeine Pouches – 5 Pack” on their shop cards, which is a content-management error rather than a product: the word caffeine appears nowhere on the pages those cards link to, and there is no Rogue caffeine pouch.
What has actually been measured
Rogue appears in three independent lab datasets, which is more than most brands this size.
Altria’s dissolution study tested Rogue Spearmint 6 mg alongside six competitors. Its funding statement needs to sit next to every figure: “This study was funded by Altria Client Services LLC, an affiliate of Helix Innovations LLC, the manufacturer of on! nicotine pouches.” All eight authors were Altria employees. With that stated, the findings are specific and consistent:
- Rogue was the heaviest pouch in the set at 0.69 g, against on! at 0.25 g and ZYN at 0.38 g.
- Its measured nicotine was 6.2 mg against a 6 mg label — slightly above, one of only three in the set that over-delivered.
- It released the least in an hour, 72%, against 98% for on! and 96% for ZYN. But the fitted curve put its ceiling at 97%, the same as theirs, so the difference is rate rather than capacity.
- Its filler was the least soluble of the seven at 41.21%, and the moistest of the dry group at 14.70% — roughly four times ZYN’s 3.52%.
- Its pH was 7.43, the second lowest measured. That figure belongs to Spearmint 6 mg; it should not be transferred to another flavour or strength.
- It was the only product in the set with measurable silicon in its filler, at 4.59%, which the authors suggest “could be due to the presence of an ingredient such as Talc”.
Roswell Park’s NCI-funded study adds the sharpest single fact about a Rogue pouch: “A delayed release was observed from Rogue pouches, where spearmint 6-mg pouches released 72.3% of their nicotine content and wintergreen 3-mg pouches released <1% at 5 minutes”. Under one per cent at five minutes. If a Rogue pouch feels like nothing for the first few minutes, that is the polacrilex matrix, and it is the expected behaviour rather than a dud can. Our Rogue Wintergreen 6 mg review and the ZYN versus Rogue wintergreen comparison cover the practical consequences.
CDC’s lab measured Rogue’s other formats in 2020 and the label accuracy was poor. Rogue held both extremes of that 70-product study: “the measured nicotine content ranged from as low as 75% below the labelled value (eg, Rogue Peppermint 2 mg lozenges) to more than 58% above the indicated strength (eg, Rogue Fruit 2 mg chewing gum)”, with Rogue lozenges “averaging 70% below”. Those were five-to-six-year-old samples of products that no longer exist in that form, and the pouches were not part of that comparison — but it is on the record, and we cover label accuracy across brands separately.
One more piece of evidence exists and it is the company’s own: a six-month prospective cohort of 1,393 adults who smoke, published in 2024 and “funded by Rogue Holdings, LLC (the Sponsor)”, with products supplied free and shipped by the sponsor. It is the source that settles the formats question, describing products “made available to participants in three forms: Pouch (6 mg nicotine), Gum (4 mg), and Lozenge (4 mg)” from the sponsor’s “commercially available portfolio” — so the 4 mg lozenge did exist and has since gone. It is also a study with no control arm, self-selected products, and this disclosure: “Thus, the study was not registered in a trial database by the Sponsor.” Its reduction and quit figures cannot support a causal claim and I would not repeat them as outcomes.
Where it is legal
No Rogue product is authorised by the FDA. FDA’s list of authorised nicotine pouch products, content current as of 30 October 2026, states: “There are 67 nicotine pouch products authorized by the FDA.” and “These are the only nicotine pouch products that may be lawfully sold in the United States.” Those 67 are listed under three manufacturer names — Helix Innovations LLC, Modoral Brands Inc. and Swedish Match USA, Inc. Searching the page for Rogue or Swisher returns nothing.
FDA attaches a standing caveat to that list which applies to the authorised products, not to Rogue: “While these products are authorized to be sold in the United States, it does not mean these products are safe, nor are they "FDA approved." All tobacco products are harmful and potentially addictive. Those who do not use tobacco products shouldn’t start.”
Being absent from that list is not the same as being rejected, and the distinction matters. I checked FDA’s warning-letter database and read the full text of all 66 letters that mention nicotine pouches: Rogue is named in none of them, while a competitor brand appears in 19 — which is the control showing the search works. Four warning letters match the word “Rogue” and none is this company: two are a vape firm and an e-liquid firm with similar names, one is an unrelated veterinary matter, and one is a drug-manufacturing letter where “rogue” is used as an ordinary adjective. No marketing denial order exists against any nicotine pouch from any company. And FDA does not publish pending applications, so whether Rogue has one before the agency can be neither confirmed nor denied. The precise position is: unauthorised, never refused, status of any application unknown.
Within the United States, the clearest map of where the brand cannot go is the one it publishes itself. Rogue’s FAQ states that “states and local regulations limit where we can ship Rogue Nicotine products” and then lists them: “We are currently unable to ship to: California, Washington, Maryland, Arkansas, Washington D.C., Utah, Massachusetts, Maine, Rhode Island, Nebraska, Oregon, and Vermont.” Five more carry regional restrictions — Colorado, Illinois, Minnesota, North Dakota and New Jersey. The company also concedes the San Francisco position in terms: “Pursuant to Article 19S of the San Francisco Health Code, flavored tobacco products including nicotine pouches may not be sold to any person or entity in San Francisco.”
That is a direct-to-consumer shipping position rather than a statement of legality, and the reasons differ by state. Two of them are flavour bans that reach tobacco-free nicotine on their own terms. Massachusetts defines a tobacco product as “a product containing or made or derived from tobacco or nicotine that is intended for human consumption”, names wintergreen and mint among the characterising flavours, and binds the maker as well as the shop: “No person, retailer or manufacturer shall sell, distribute, cause to be sold or distributed, offer for sale any flavored tobacco product … in any retail establishment, online or through any other means to any consumer in the commonwealth”. California’s ban works differently — the Attorney General’s own page says section 104559.5 “prohibits the retail sale of most flavored tobacco products”, and a federal court has read S.B. 793 as regulating retailers rather than manufacturers. But the category is caught: the California AG has formally determined that pouch products are presumptively flavoured under the ban, using ZYN as the test case. We cover the state position in detail on where to buy nicotine pouches in California.
Outside the United States, the brand appears not to operate at all. Shipping is UPS Ground with continental-US promotions only, payment is US dollars under Florida law, the terms disclaim use “in any jurisdiction or country where such distribution or use would be contrary to law or regulation”, and the privacy policy contains no GDPR, EEA or UK provisions whatsoever — all of which a consumer business selling into Europe would have. No EU or UK Rogue site is linked from anywhere on either company’s pages. On its manufacturer’s own evidence this is a US-only brand. Whether cans reach Europe through resellers I cannot say from any manufacturer source, and the brand name is generic enough that a “Rogue” pouch on a European site may be an unrelated product.
Counterfeits
There is nothing brand-specific on the public record, and I looked hard enough to say so rather than guess.
Rogue publishes no authenticity guidance of any kind. Across every Rogue and Swisher page I downloaded, the words “counterfeit”, “genuine”, “authorized retailer” and “tamper” return zero hits. There is no serial check, no QR authentication, no authorised-seller list and no “how to spot a fake” page. Separately: none of the 66 FDA warning letters mentioning nicotine pouches contains the word counterfeit, and a search of federal court records for “Rogue Holdings” returns no matters at all — no trademark dispute, no counterfeiting action, no seizure forfeiture. Two routes I could not check are recorded as unavailable rather than clear: the US trademark search front end is behind a bot challenge, and Customs’ newsroom search returned a 403.
What is sourceable is a category-level concern. A non-industry review in 2025 noted that “the lack of regulation and manufacturer oversight also increases the threat of counterfeit products which compromise quality and pose health risks” — but its supporting references are about counterfeit e-cigarettes and illicit smokeless tobacco, not counterfeit pouches. So the honest statement is that counterfeiting is a plausible risk for an unregulated category and an undocumented one for this brand.
In practice, the useful protection is channel rather than packaging. Buy from the manufacturer or an established bricks-and-mortar retailer rather than a marketplace listing, and treat a price far below the usual as the signal it is. I cannot tell you what a fake Rogue can looks like, because nobody has published one.
Verdict
Rogue is a technically unusual brand with a straightforward commercial position. The polacrilex matrix is the whole story: it makes the pouches heavier than anything else measured, slower off the mark to the point where a 3 mg wintergreen released under 1% of its nicotine in five minutes, and lower in pH than most of the category. If you want an immediate hit, this is the wrong brand. If you want something that builds over a long sitting, the same property is the reason to try it.
The strength ladder is genuinely broad — 3 to 15 mg across two lines is wider than most US-available brands offer — and the label, on the one pouch that has been independently measured, was honest to within 3%. Set against that: nothing in the range is FDA-authorised, a dozen states and the District of Columbia are closed to its own shipping channel, the published specifications are thinner than ZYN’s or Velo’s, and three separate inconsistencies on the manufacturer’s own shop mean you cannot take a figure from it without checking.
If you are deciding between brands rather than researching one, our master ranking and the brand directory are the better starting points, and on!, ZYN and Velo have guides of their own.
Sources
- FDA, Nicotine Pouch Products Authorized by the FDA — content current as of 30 October 2026, read 3 November 2026. 67 products, three manufacturer names, no Rogue entry.
- FDA, Tobacco Products Marketing Orders, and FDA’s warning-letter database (all 65 letters mentioning nicotine pouches read in full).
- Platt SP et al. Dissolution and physical characterization of oral nicotine pouch products. Scientific Reports, PMID 41495155. Funded by Altria Client Services LLC, an affiliate of the manufacturer of on!; all eight authors were Altria employees.
- Page MK et al. Comparison of Nicotine and Selected Flavoring Contents Between Tobacco-Free and Tobacco-Containing Oral Pouches. Nicotine & Tobacco Research, PMID 40383714. Funded by the National Cancer Institute.
- Tran H et al. Total and unprotonated (freebase) nicotine content in new types of oral ‘tobacco-free’ nicotine products. Tobacco Control, PMID 39542719. CDC Division of Laboratory Sciences; 2020 samples.
- Effect of fruit and mint flavored Rogue oral nicotine product use on smoking reduction and quitting in a 6-month prospective cohort. BMC Public Health 24:3249, PMID 39578809. Funded by Rogue Holdings, LLC; not registered in any trial database; no control arm.
- Nicotine pouches: a narrative review of the existing literature. Frontiers in Public Health 2025. Authors declare no commercial or financial relationships.
- M.G.L. c. 270 § 28 (Massachusetts flavoured tobacco); California Attorney General, flavoured tobacco ban and the AG’s notice of determination 24-11-A9.
- Manufacturer pages, read 3 November 2026: Rogue FAQs, Rogue products, Rogue terms of use, Swisher International business units.
Last verified 3 November 2026. No score is given on this page because a brand guide is not a product test; the scored reviews are linked above. No Rogue retailer is named.
